'Transformative' HIV PrEP shot slowly overcomes cost hurdles

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
Opinion
R Street InstituteOpinion

R Street Testimony in Support of GA SB 195, Authorizing pharmacists to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions

Chelsea Boyd, Research Fellow, Integrated Harm Reduction, R Street Institute In SUPPORT of Senate Bill 195, “Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure ...
Newsweek

HIV Breakthrough as New Injection 89% More Effective Than PrEP

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
Seeking Alpha

ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
Infectious Disease Advisor

DoxyPEP Lowers STI Positivity Rate Among PrEP Users

Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
Nasdaq

Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups

Pre-exposure prophylaxis clinical trials of a 3-dose regimen of Verorab® followed by a booster dose at 1 year in adults and children achieved an adequate immune response.1 Of those who had a booster ...
EurekAlert!

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
Monthly Prescribing Reference

Preexposure Prophylaxis Use Increased in Recent Years

There was an increase in the annual number of PrEP users from 10,281 in 2013 to 505,730 in 2023. HealthDay News — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a ...